netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Chapter Links...
 Details...
03.03  Expand sub section  Cromoglicate, related therapy and leukotriene receptor antagonists
03.03.01  Expand sub section  Cromoglicate and related therapy
Sodium Cromoglicate (Intal®)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
03.03.02  Expand sub section  Leukotriene receptor antagonists
Montelukast (Singulair®)
View adult BNF View SPC online View childrens BNF
Formulary

Green Traffic Light  In line with Maintenance Management of Asthma – Inhaled and Oral Therapies (adults).

APCO September 2017.

Brown Traffic Light  For spontaneous urticaria in line with Management Guideline for Spontaneous Urticaria with/without Angioedema in Adults

APCO November 2017.

 
Link  Medicines for Children leaflet: Montelukast for asthma
   
03.03.03  Expand sub section  Phosphodiesterase type-4 inhibitors
Roflumilast (Daxas®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

For treating chronic obstructive pulmonary disease as per NICE TA461. To be initiated by the specialist and transferred to GP after three months in line with Roflumilast amber continuation guideline. 

APCO November 2017.

 
Link  NICE TA461: Roflumilast for treating chronic obstructive pulmonary disease
   
 ....
 Non Formulary Items
Nedocromil  (Tilade® CFC-free inhaler)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Zafirlukast  (Accolate®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary